These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34257675)

  • 21. [The effect of omega-3 fatty acids on risk factors for cardiovascular diseases].
    Yam D; Bott-Kanner G; Genin I; Shinitzky M; Klainman E
    Harefuah; 2001 Dec; 140(12):1156-8, 1230. PubMed ID: 11789299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial.
    Samimi M; Jamilian M; Asemi Z; Esmaillzadeh A
    Clin Nutr; 2015 Jun; 34(3):388-93. PubMed ID: 24973862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
    Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
    J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.
    Friday KE; Childs MT; Tsunehara CH; Fujimoto WY; Bierman EL; Ensinck JW
    Diabetes Care; 1989 Apr; 12(4):276-81. PubMed ID: 2707115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractions.
    Thomas TR; Smith BK; Donahue OM; Altena TS; James-Kracke M; Sun GY
    Metabolism; 2004 Jun; 53(6):749-54. PubMed ID: 15164323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma -linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study.
    Birudaraju D; Cherukuri L; Kinninger A; Chaganti BT; Shaikh K; Hamal S; Flores F; Roy SK; Budoff MJ
    Clin Nutr ESPEN; 2020 Feb; 35():174-179. PubMed ID: 31987113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cadmium and nickel co-exposure exacerbates genotoxicity and not oxido-inflammatory stress in liver and kidney of rats: Protective role of omega-3 fatty acid.
    Owumi SE; Olayiwola YO; Alao GE; Gbadegesin MA; Odunola OA
    Environ Toxicol; 2020 Feb; 35(2):231-241. PubMed ID: 31639282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ω-3 Fatty Acids Ethyl Esters Suppress Cerebral Vasospasm and Improve Clinical Outcome Following Aneurysmal Subarachnoid Hemorrhage.
    Nakagawa I; Yokoyama S; Omoto K; Takeshima Y; Matsuda R; Nishimura F; Yamada S; Yokota H; Motoyama Y; Park YS; Nakase H
    World Neurosurg; 2017 Mar; 99():457-464. PubMed ID: 27993744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial.
    Ihm SH; Chung WB; Lee JM; Hwang BH; Yoo KD; Her SH; Song WH; Chae IH; Park TH; Kim JH; Jeon DW; Cho BR; Kang SH; Park SD; Lee JB; Woo JT; Lee BW; Han KA; Won KH; Kim HS; Yu JM; Chung CH; Kim HJ; Cho HC; Seung KB
    Clin Ther; 2020 Oct; 42(10):2021-2035.e3. PubMed ID: 32891418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of omega-3 fatty acid supplementation on tumor-bearing rats.
    Ramos EJ; Middleton FA; Laviano A; Sato T; Romanova I; Das UN; Chen C; Qi Y; Meguid MM
    J Am Coll Surg; 2004 Nov; 199(5):716-23. PubMed ID: 15501111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Galletti F; Fazio V; Gentile M; Schillaci G; Pucci G; Battista F; Mercurio V; Bosso G; Bonaduce D; Brambilla N; Vitalini C; D'Amato M; Giacovelli G
    Lipids Health Dis; 2019 Mar; 18(1):66. PubMed ID: 30885221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
    Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
    Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
    Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
    Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    J Diabetes Complications; 2017 Sep; 31(9):1394-1400. PubMed ID: 28716357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment with and ongoing use of omega-3 fatty acid ethyl esters reduce the slow-flow phenomenon and prevent in-stent restenosis in patients undergoing carotid artery stenting.
    Nakagawa I; Park HS; Yokoyama S; Wada T; Yamada S; Motoyama Y; Kichikawa K; Nakase H
    J Vasc Surg; 2017 Jul; 66(1):122-129. PubMed ID: 28359716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial.
    Sandhu N; Schetter SE; Liao J; Hartman TJ; Richie JP; McGinley J; Thompson HJ; Prokopczyk B; DuBrock C; Signori C; Hamilton C; Calcagnotto A; Trushin N; Aliaga C; Demers LM; El-Bayoumy K; Manni A
    Cancer Prev Res (Phila); 2016 Apr; 9(4):275-82. PubMed ID: 26714774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
    Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
    Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.
    Esposito K; Marfella R; Ciotola M; Di Palo C; Giugliano F; Giugliano G; D'Armiento M; D'Andrea F; Giugliano D
    JAMA; 2004 Sep; 292(12):1440-6. PubMed ID: 15383514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.